Avalo Therapeutics, Inc.
Ticker: AVTX
| Insider | Title |
|---|---|
| Aaron Kantoff | Director |
| Capital Management Ltd. Caissa | 10% or greater ownership |
| Capital Master Fund Ltd. Armistice | 10% or greater ownership |
| Capital, Llc Armistice | 10% or greater ownership |
| Christopher Ryan Sullivan | Chief Financial Officer |
| Garry Arthur Neil | CEO and Chairman of the Board, Director |
| Gilla Kaplan | Director |
| H Jeffrey Wilkins | Chief Medical Officer |
| Illya Keith Maher | Director |
| James Archie Jr Harrell | Chief Commercial Officer |
| Jonathan Goldman | Director |
| Joseph M Miller | Director |
| June Sherie Almenoff | Director |
| Magnus Persson | Director |
| Michael F Cola | Chief Executive Officer, Director |
| Mitchell Chan | Director |
| Mittie Doyle | Chief Medical Officer |
| Paul Varki | Chief Legal Officer |
| Phil Gutry | CHIEF BUSINESS OFFICER |
| Samantha Truex | Director |
| Schond L. Greenway | CFO |
| Sol J Barer | Director |
| Stephen Smolinski | Chief Commercial Officer |
| Steven Boyd | 10% or greater ownership |
| Suzanne Louise Bruhn | Director |